Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SELADELPAR LYSINE for Primary biliary cholangitis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 39 adverse event reports in the FDA FAERS database where SELADELPAR LYSINE was used for Primary biliary cholangitis.

Most Reported Side Effects for SELADELPAR LYSINE

Side Effect Reports % Deaths Hosp.
Aspartate aminotransferase increased 10 9.4% 0 0
Alanine aminotransferase increased 9 8.4% 0 0
Blood alkaline phosphatase increased 9 8.4% 0 0
Headache 8 7.5% 0 0
Dizziness 7 6.5% 0 1
Drug ineffective 6 5.6% 0 0
Pruritus 6 5.6% 0 0
Abdominal distension 5 4.7% 0 0
Diarrhoea 5 4.7% 0 0
Hepatic enzyme increased 5 4.7% 0 0
Nausea 5 4.7% 0 0

Other Indications for SELADELPAR LYSINE

Product used for unknown indication (59)

Other Drugs Used for Primary biliary cholangitis

OBETICHOLIC ACID (4,838) ELAFIBRANOR (288) URSODIOL (203) FENOFIBRATE (40) SELADELPAR (36) AZATHIOPRINE (14) BEZAFIBRATE (13) PREDNISONE (11) RITUXIMAB (11) BUDESONIDE (8)

Related Pages

SELADELPAR LYSINE Full Profile All Primary biliary cholangitis Drugs SELADELPAR LYSINE Demographics SELADELPAR LYSINE Timeline